BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7150322)

  • 1. Regulation of glycophorin of complement activation via the alternative pathway.
    Okada N; Yasuda T; Tsumita T; Shinomiya H; Utsumi S; Okada H
    Biochem Biophys Res Commun; 1982 Sep; 108(2):770-5. PubMed ID: 7150322
    [No Abstract]   [Full Text] [Related]  

  • 2. Species-specific inhibition by glycophorins of complement activation via the alternative pathway.
    Okada H; Tanaka H
    Mol Immunol; 1983 Nov; 20(11):1233-6. PubMed ID: 6656770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction of alternative complement pathway activation by sialosylglycolipids.
    Okada N; Yasuda T; Okada H
    Nature; 1982 Sep; 299(5880):261-3. PubMed ID: 7110347
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of human glycophorin A and saccharides on the invasion of human erythrocytes by Plasmodium falciparum].
    Li JX; Zhou YC; Wei YM
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1986; 4(2):86-9. PubMed ID: 3533309
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1982 Jan; 45(1):115-24. PubMed ID: 6173312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish (Ictalurus punctatus).
    Ourth DD; Bachinski LM
    Dev Comp Immunol; 1987; 11(3):551-64. PubMed ID: 3678558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid.
    Michalek MT; Mold C; Bremer EG
    J Immunol; 1988 Mar; 140(5):1588-94. PubMed ID: 3346543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the interaction of HVJ (Sendai Virus) with liposomal membranes. HVJ-induced permeability increase of liposomes containing glycophorin.
    Oku N; Nojima S; Inoue K
    Virology; 1982 Jan; 116(2):419-27. PubMed ID: 6278721
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
    J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
    [No Abstract]   [Full Text] [Related]  

  • 11. Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.
    Nydegger UE; Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6078-82. PubMed ID: 282625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycolipids and glycophorin on the activity of human interferon-beta and -gamma.
    Fuse A; Handa S; Kuwata T
    Antiviral Res; 1982 Aug; 2(3):161-6. PubMed ID: 6814359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycophorin A interferes in the agglutination of human erythrocytes by concanavalin A. Explanation of the requirement for enzymic predigestion.
    Gokhale SM; Mehta NG
    Biochem J; 1987 Jan; 241(2):505-11. PubMed ID: 3297033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
    Hirsch RL; Griffin DE; Winkelstein JA
    J Immunol; 1981 Nov; 127(5):1740-3. PubMed ID: 6117595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
    Okada N; Yasuda T; Okada H
    J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycophorin-induced differentiation of human myelogenous leukemic cell lines.
    Murayama J; Sakagami H; Takeda M
    Anticancer Res; 1997; 17(4A):2545-8. PubMed ID: 9252678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curdlan, a (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO13140, activates the alternative complement pathway by heat treatment.
    Matsushita M
    Immunol Lett; 1990 Oct; 26(1):95-7. PubMed ID: 2276766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of C3 molecules to membranes via the SH-residue generated by the cleavage of a thioester bond can initiate complement activation.
    Okada N; Yasuda T; Okada H
    Biochem Biophys Res Commun; 1988 Mar; 151(2):743-8. PubMed ID: 3348808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of phagocytosis by erythrocyte membrane sialoglycoprotein on target liposomes.
    Utsumi S; Shinomiya H; Minami J; Sonoda S
    Immunology; 1983 May; 49(1):113-20. PubMed ID: 6840799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.